170 related articles for article (PubMed ID: 37584783)
61. Thoracic Radiotherapy Effect on the Outcome in Extensive Stage Small Cell Lung Cancer.
Sedef AK; Yildirim BA; Sumbul AT; Ozyilkan O
J Coll Physicians Surg Pak; 2023 Feb; 33(2):188-192. PubMed ID: 36797629
[TBL] [Abstract][Full Text] [Related]
62. Intrathoracic extensive-stage small cell lung cancer: assessment of the benefit of thoracic and brain radiotherapy using the SEER database.
Mahmoud O; Kwon D; Greenfield B; Wright JL; Samuels MA
Int J Clin Oncol; 2016 Dec; 21(6):1062-1070. PubMed ID: 27380168
[TBL] [Abstract][Full Text] [Related]
63. Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients.
Okamoto K; Okamoto I; Takezawa K; Tachibana I; Fukuoka M; Nishimura Y; Nakagawa K
Jpn J Clin Oncol; 2010 Jan; 40(1):54-9. PubMed ID: 19837690
[TBL] [Abstract][Full Text] [Related]
64. Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study.
Luan Z; Wang Z; Huang W; Zhang J; Dong W; Zhang W; Li B; Zhou T; Li H; Zhang Z; Wang Z; Sun H; Yi Y
Exp Ther Med; 2015 Aug; 10(2):671-678. PubMed ID: 26622373
[TBL] [Abstract][Full Text] [Related]
65. Long-term survival in extensive-stage small-cell lung cancer treated with different immune checkpoint inhibitors in multiple-line therapies: A case report and literature review.
Zhang X; Zheng J; Niu Y; Xue C; Yu Y; Tan K; Cui H
Front Immunol; 2022; 13():1059331. PubMed ID: 36532013
[TBL] [Abstract][Full Text] [Related]
66. Current patterns of care for patients with extensive stage small cell lung cancer: Survey of US radiation oncologists on their recommendations regarding thoracic consolidation radiotherapy.
Mitin T; Jain A; Degnin C; Chen Y; Henderson M; Thomas CR
Lung Cancer; 2016 Oct; 100():85-89. PubMed ID: 27597285
[TBL] [Abstract][Full Text] [Related]
67. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
Halvorsen TO; Sundstrøm S; Fløtten Ø; Brustugun OT; Brunsvig P; Aasebø U; Bremnes RM; Kaasa S; Grønberg BH
Acta Oncol; 2016 Nov; 55(11):1349-1354. PubMed ID: 27549509
[TBL] [Abstract][Full Text] [Related]
68. Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer.
Shimada M; Yamaguchi H; Fukuda M; Tomono H; Honda N; Dotsu Y; Taniguchi H; Gyotoku H; Senju H; Takemoto S; Ikeda T; Nakatomi K; Nakamura Y; Nagashima S; Yamazaki T; Mukae H
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1059-1064. PubMed ID: 31486872
[TBL] [Abstract][Full Text] [Related]
69. Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy.
Stanic K; Vrankar M; But-Hadzic J
Radiol Oncol; 2020 Jul; 54(3):353-363. PubMed ID: 32726294
[TBL] [Abstract][Full Text] [Related]
70. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
71. Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235.
Bogart JA; Watson D; McClay EF; Evans L; Herndon JE; Laurie F; Seagren SL; Fitzgerald TJ; Vokes E; Green MR
Lung Cancer; 2008 Oct; 62(1):92-8. PubMed ID: 18367288
[TBL] [Abstract][Full Text] [Related]
72. Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies.
Hu X; Xia B; Bao Y; Xu YJ; Wang J; Ma HL; Peng F; Jin Y; Fang M; Tang HR; Chen MY; Dong BQ; Jin JN; Fu XL; Chen M
Strahlenther Onkol; 2020 Feb; 196(2):172-181. PubMed ID: 31784801
[TBL] [Abstract][Full Text] [Related]
73. Thoracic radiation therapy could give survival benefit to elderly patients with extensive-stage small-cell lung cancer.
An C; Jing W; Zhang Y; Liu S; Wang H; Zhu K; Kong L; Guo H; Zhu H
Future Oncol; 2017 Jun; 13(13):1149-1158. PubMed ID: 28326834
[TBL] [Abstract][Full Text] [Related]
74. Optimal timing of thoracic radiotherapy in limited stage small cell lung cancer (SCLC) with daily fractionation: A brief report.
Hasan S; White R; Renz P; Abel S; Otaibi Z; Monga D; Colonias A; Wegner RE
Radiother Oncol; 2019 Mar; 132():23-26. PubMed ID: 30825965
[TBL] [Abstract][Full Text] [Related]
75. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
[TBL] [Abstract][Full Text] [Related]
76. [Effects of Local Radiation Combined with Chemotherapy in the treatment of
Patients with Extensive-stage Small Cell Lung Cancer].
Wu D; Fang J; Nie J; Dai L; Chen X; Zhang J; Hu W; Han J; Ma X; Tian G; Han S; Long J; Wang Y
Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):272-9. PubMed ID: 25975297
[TBL] [Abstract][Full Text] [Related]
77. Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II study.
Kong T; Chen L; Zhao X; Duan F; Zhou H; Wang L; Liu D
Invest New Drugs; 2022 Oct; 40(5):1095-1105. PubMed ID: 35788937
[TBL] [Abstract][Full Text] [Related]
78. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
Bogart JA; Herndon JE; Lyss AP; Watson D; Miller AA; Lee ME; Turrisi AT; Green MR;
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):460-8. PubMed ID: 15145163
[TBL] [Abstract][Full Text] [Related]
79. Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer.
Berta J; Rózsás A; Megyesfalvi Z; Ostoros G; Döme B
Curr Opin Oncol; 2023 Jan; 35(1):54-60. PubMed ID: 36420570
[TBL] [Abstract][Full Text] [Related]
80. Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy.
Kang K; Wu Y; Yao Z; Lu Y
Cancer Lett; 2023 Jul; 565():216239. PubMed ID: 37211066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
